ARID3A and liver cancer: Furthermore, positive ARID3A expression was found in 45 of the 111 (40.5%) primary liver cancer samples and in 23 of the 123 (18.7%) adjacent NT tissues in cohort III (P = 0.0002) (Fig. 1H).